The Senate health committee convened on Wednesday to consider three of President Donald Trump’s nominees for senior leadership roles at the Department of Health and Human Services (HHS), a proceeding that brings renewed scrutiny to the administration’s leadership team.
Among the nominees is Dr. Nicole Saphier, a radiologist selected as Trump’s third choice for surgeon general. The position has experienced significant turbulence during the current administration. Trump’s initial pick, Fox News medical contributor Dr. Janette Nesheiwat, was withdrawn after concerns were raised regarding her academic credentials. Dr. Casey Means, the second nominee, saw her nomination collapse following a contentious February hearing and a previously cancelled first appearance due to her going into labor; the committee never held a vote on her nomination.
Also testifying before senators is Chris Klomp, a former health technology executive nominated to serve as HHS deputy secretary. Klomp has overseen much of the department’s day-to-day operations since February, having risen through the ranks from his role as director of the Center for Medicare. Described as a pragmatic leader rather than a media personality or politician, Klomp is expected to face intense questioning. Preliminary indicators from a Tuesday hearing before the Senate Finance Committee suggest senators will press him on topics including measles outbreaks, abortion medication, drug pricing, and vaccines.
Completing the trio of nominees is Dr. Timothy Westlake, an emergency medicine physician based in Wisconsin, who is up for confirmation as the assistant secretary for Mental Health and Substance Use.
The hearings take place against a backdrop of strained relations between the Senate committee and HHS Secretary Robert F. Kennedy Jr. Kennedy, whose confirmation was marked by promises he has since broken, has made infrequent appearances before the committee. When he does appear, the interactions have often been described as chaotic and combative, casting a shadow over the proceedings for his appointees.
Wait, didn’t Casey Means’ nomination collapse after she went into labor? This administration’s vetting is wild.
Does anyone else find it concerning that Kennedy Jr. barely shows up? Accountability seems optional now.
Saphier is the third choice? That speaks volumes about how chaotic these HHS appointments have been recently.
I hope they grill Klomp hard on drug pricing. That impacts every American family directly.
Another turbulent confirmation cycle for surgeon general? The process seems deeply broken at this point.